Skip to content

Tumor-related aphasia: Risk assessment with TMS mapping and long-term assessment of aphasia in patients with intracranial tumors

Tumor-related aphasia: Risk assessment with TMS mapping and long-term assessment of aphasia in patients with intracranial tumors

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00039236
Enrollment
40
Registered
2026-02-17
Start date
2024-06-03
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C69-C72

Interventions

Group 1: Study arm 1 focuses on preoperative language mapping using transcranial magnetic stimulation (TMS). The mapping is conducted using not only the standard task of object naming but also a newly
Nasreddine et al., 2005), the Berlin Aphasia Score (Tuncer et al., 2021), as well as reaction time measurements during the sentence completion task.

Sponsors

Universitätsklinik für Neurochirurgie, Evangelisches Klinikum Bethel
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Suspected brain tumor (imaging-based suspected diagnosis), clinically assessed relevant risk of postoperative speech disorder

Exclusion criteria

Exclusion criteria: Preoperative language level below the requirements of the language tasks performed, contraindications for transcranial magnetic stimulation (cardiac pacemaker, cochlear implant, intracranial clips)

Design outcomes

Primary

MeasureTime frame
TMS parameters for the object naming task and sentence completion task are recorded, including the number of errors, error rates, error locations, and types of errors. In addition, as part of preoperative planning, the reconstructability of fiber tracts (based on routine MRI sequences) and their concordance to the TMS-identified sites are assessed. The endpoints of study arm 2 are the test scores obtained from the applied instruments (MoCA and BAS) as well as reaction times during the sentence completion task. These assessments are conducted preoperatively (T1) and at 3 days (T2), 3 months (T3), and 1 year (T4) after tumor resection.

Countries

Germany

Contacts

Public ContactJohanna Scholtz

Universitätsklinik für Neurochirurgie, Evangelisches Klinikum Bethel

johanna.scholtz@evkb.de+49 52177278420

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026